CW June 2003
Volume 12Issue Number 6 June 2003 ISSN 10593802 Intravenous Bisphosphonate Helps Prostate Cancer Bone Loss, Pain PreventionA potent new intravenous (IV) bisphosphonate can protect prostate cancer patients taking hormone therapy from the loss of bone, a frequent serious drawback of androgen deprivation. Indeed, the use of the bisphosphonate can even augment the men?s bone-mineral density.
Go to Previous Page Source & Additional Reading American Society of Clinical Oncology Annual Meeting. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW June 2003Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
